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Abstract: Marine environments account for over 90% of the biosphere and hold tremendous
potential for biotechnological applications and drug discovery. To fully exploit this potential
and develop interesting discoveries into useful molecular tools and successful products, a
multidisciplinary approach is indispensable. Here, we introduce the European Marine Biological
Research Infrastructure Cluster (EMBRIC), a novel collaborative initiative that aims to facilitate
translational marine science and remove existing bottlenecks that are currently impeding blue
innovation. In the context of this initiative, pilot projects have been designed to test the functionality
of the cluster focusing on two specific sectors of marine biotechnology: (i) the discovery and
exploitation of marine natural products and (ii) the marker-assisted selection of desirable traits
in aquaculture. EMBRIC brings together the expertise of six European Research Infrastructures on
accessing the potential of marine organisms, specifically on the 99% of bacteria yet to be grown in
culture, the microalgae, finfish, and shellfish. It improves the throughput and efficiency of workflows
for discovery of novel marine products and facilitates projects that require an interdisciplinary
approach. The objective is to develop coherent chains of high quality services for access to biological,
analytical, and data resources by deploying common underpinning technologies and practices.
The connection of academic science with industry is being strengthened by engaging companies, as
well as geographically separated public and private-sector communities in the domain of marine
biotechnology, and by federating technology transfer services amongst the players involved.
Keywords: marine biotechnology; microorganisms; microalgae; finfish; research infrastructure;
discovery pipeline; bioactive compounds
1. Introduction
In addition to providing food for mankind and livestock, the oceans represent a vast reservoir
of genetic diversity that can potentially be harnessed to drive scientific innovation and develop new
products. The establishment of numerous marine stations since the 19th century has greatly facilitated
access to marine organisms; however, most stations are relatively remote from major centres of life
sciences research, which provide the interdisciplinary skill sets and large scale infrastructure required
for modern biological research. This problem has become even more acute following the advent of
‘omics’ technologies. European Research Infrastructures represent an attractive means of bridging this
gap by providing leading expertise and state-of-the-art life sciences facilities to marine biologists, and
by making marine model organisms accessible to a wide range of researchers.
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2. European Research Infrastructures: Promoting Large Scale and Interdisciplinary Research
Since its inauguration in 2002, the European Strategy Forum on Research Infrastructures
(ESFRI) has been driving the development of numerous Research Infrastructures with the aim of
promoting multidisciplinary collaborations across Europe in order to accelerate scientific discoveries.
The underlying idea is very simple: a Research Infrastructure typically combines expertise and
capital-intensive instrumentation used in a certain field of research and makes those resources
available to the broad scientific community, which in turn allows non-specialist users to readily tap
into new research areas without having to start from scratch every time they want to supplement their
projects with an experiment outside their core competencies or capacities. This powerful approach,
which is somewhat reminiscent of smaller-scale core facilities belonging to individual universities
or research institutes, has been deemed widely useful by the scientific community, and the latest
ESFRI Roadmap published in 2016 now comprises 21 Research Infrastructures that cover a broad
scientific spectrum, including, amongst others, the fields of environmental, health, and food research
(see https://ec.europa.eu/research/infrastructures/index_en.cfm?pg=esfri).
3. EMBRIC: Driving Innovation through Collaboration
This research infrastructure approach is particularly attractive for specialized research centres,
such as marine stations, that, although highly skilled in their field of expertise, may lack the know-how
to perform the downstream experiments that are indispensable for translating basic research findings
into molecular tools and marketable products. The Horizon 2020 EU-funded European Marine
Biological Research Infrastructure Cluster (EMBRIC) emerged in 2015 in order to close this gap and
boost translational research. The EMBRIC cluster aims to build a dynamic network of partners
from established and emerging research infrastructures to advance the field of marine biotechnology.
The EMBRIC project includes experimental pilot projects focusing on two specific sectors of marine
biotechnology: (i) aquaculture genetics and breeding, and (ii) discovery and exploitation of marine
natural products from microalgae and marine microbes (Figure 1). A total of 29 scientific partners
(i.e., universities, research institutes, non-profit organizations, and SMEs), most of which are also
members of a European Research Infrastructure, have joined forces and generated a comprehensive
map of all resources available within the EMBRIC network with the ultimate goal to make those
resources (i.e., facilities, technologies, marine organisms, data, and experimental know-how) broadly
accessible to the scientific community (see http://www.embric.eu/).
In a nutshell, EMBRIC’s mission is to provide continuous support throughout each and every step
of the marine discovery workflow—from the discovery of novel marine organisms all the way to the
final molecular tool or commercial product. This is possible because most of the partner institutions
are already embedded in one of the six participating Research Infrastructures that collectively cover
the relevant scientific disciplines for marine biotechnology (see Table 1). This combination of expertise
has allowed EMBRIC to reach the critical mass necessary to effectively provide support in a variety
of interconnecting areas—ranging from characterization and cataloguing of novel marine organisms
through to the extraction of promising biomolecules, optimization experiments, and technology
transfer support. EMBRIC’s mission is not restricted to marine biologists. Translating any basic
research result into a useful tool generally requires a cross-disciplinary approach and typically involves
multiple partners from different research fields. Hence, EMBRIC engages extensively in showcasing
its marine research results to interested stakeholders within and outside the immediate network
such as, for example, pharmaceutical and biotech companies. By establishing such contacts between
people who would otherwise not meet, EMBRIC envisages enabling numerous mutually beneficial
collaborations throughout its lifetime that will benefit both the peripheral maritime region and the
application-oriented collaborator usually located more inland. In this context, it is EMBRIC’s broad
positioning across different scientific disciplines that will allow for an effective selection of suitable
collaborators and subsequent matchmaking.
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Table 1. European Research Infrastructures participating in EMBRIC and their respective fields
of expertise.
Research Infrastructure Field of Expertise
EMBRC ERIC Isolation, characterization, cultivation, and cataloguing of marine organisms
MIRRI Isolation, characterizatio , cultiv tion, and cataloguing of marine microorganisms
EU-OPENSCREEN ERIC Bioprofiling, high throughput screening, and medicinal chemistry approaches forhit-to-lead optimiz tion
Elixir Data handling and long-term storage of data in databases
AQUAEXCEL 2020 Integration and standardisation of tools for aquaculture research
RISIS Science and innovation studies, investigation of research and innovationdynamics, and policies
4. I troducing th Players Involv d
Usually, blue innovation starts in the ocean with the identification of novel organisms with
interesting characteristics. To approach this critical first step in a systematic manner, the European
Marine Biological Resource Centre (EMBRC, see http://www.embrc.eu/) Research Infrastructure
and the Microbial Resources Research Infrastructure (MIRRI, see http://www.mirri.org) are jointly
focusing their efforts on isolating, characterizing, and cataloguing novel marine species. To this
end, both partners provide access to marine and coastal ecosystems, marine model organisms, and
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numerous culture collections. MIRRI has a clear focus on microorganisms, while EMBRC covers a
broader spectrum of marine species. Hence, these two research infrastructures collectively ensure
maximum coverage of marine biodiversity within the EMBRIC network.
A major constraint in accessing the potential of marine microorganisms is our inability to isolate
and subsequently grow them. This aspect is being addressed by MIRRI, and novel tools to access these
organisms and their chemistry are being explored. Access to state of the art equipment such as novel
‘omics’ and imaging technologies allows EMBRC and MIRRI to perform thorough characterization of
newly isolated species, and longstanding expertise in cultivation and cataloguing of marine organisms
ensures that interesting biomaterial is readily accessible and available in appropriate quantities for
downstream experiments.
Once a novel organism has been characterized, catalogued, and cultivated successfully,
EU-OPENSCREEN, the European Research Infrastructure for high throughput screening and medicinal
chemistry (see http://www.eu-openscreen.eu/), provides support for scientists who are interested
in isolating and testing marine natural products for interesting bioactivities. Here, the expertise
of EU-OPENSCREEN includes assistance during extraction and fractionation of natural products,
as well as initial bioprofiling in order to obtain bioactivity profiles from newly isolated marine
biomolecules. Moreover, EU-OPENSCREEN invites scientists to subsequently donate their newly
discovered compounds to the EU-OPENSCREEN compound library. Once archived in this library,
the donated compounds will be used routinely in all subsequent high throughput screens performed
at a total of 20 European EU-OPENSCREEN partner sites. The donating scientist automatically
receives updates every time a donated compound generates a hit in a screening campaign. In this way,
the compound-providing scientist gets a better chemical understanding of the donated compound
and its bioactivity profile over time. Moreover—subsequent to a primary hit in a biological
assay—EU-OPENSCREEN also offers support in hit-to-lead optimization, which allows for the
optimization of desired compound properties and thus allows for the transformation of a promising
candidate compound into a useful molecular tool or drug candidate.
As a lot of scientific results are produced on the route to discovery, managing and safeguarding
data along the way is of utmost importance to ensure reproducibility and successful translation of
basic research results. The Research Infrastructure ELIXIR (see https://www.elixir-europe.org/) is
specialized in handling large amounts of biological data and ensures effective collection, quality control,
and secure storage of, as well as ready access to, all data generated within the EMBRIC network. In this
context, it is a key challenge to make as much data available for public use as possible while, at the
same time, restricting access to those datasets that will be used to generate intellectual property.
Two additional infrastructures bring added depth to the EMBRIC consortium: AQUAEXCEL2020
(see http://www.aquaexcel2020.eu/) provides a pan-European association of aquaculture research
facilities, whilst the Research Infrastructure for Research and Innovation Policy Studies (RISIS,
see http://risis.eu/) addresses research and innovation dynamics. In the context of EMBRIC,
AQUAEXCEL2020, a European Commission Integrated Infrastructure Initiatives project that focuses on
marker-assisted genetic selection in aquaculture of finfish, provides the EMBRIC research community
with biological resources (finfish) and access to a wide range of production systems (including
recirculation, flow-through, hatchery, cage, and pond systems), as well as associated expertise.
The Integrating Activity project RISIS is specialized in the analysis of innovation ecosystems
across Europe and, in close collaboration with the Technology Transfer Officers of EMBRIC partner
institutions, is involved in establishing the technology transfer identity of EMBRIC. Generation of
intellectual property (IP) is a complex task, and experimental scientists usually get exposed to IP-related
issues only to a limited extent. Hence, in order to be able to support scientists at advanced stages of
their marine discovery projects, EMBRIC combines expertise and best practices regarding intellectual
property. To this end, Technology Transfer Officers of the 29 EMBRIC partner institutions meet on
a regular basis to nurture exchange of expertise and establish common guidelines for generation of
intellectual property. These guidelines, in conjunction with EMBRIC’s large network of Technology
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Transfer Officers, will ensure a quick turnaround time for all issues related to technology transfer and
generation of intellectual property. In addition, RISIS is also in the process of gathering, consolidating,
harmonizing, and making available a total of 14 databases, covering topics such as the dynamics of
innovation and the evaluation of research policies (http://datasets.risis.eu/).
Figure 2 summarizes the engagement of the participating Research Infrastructures and industrial
partners in the EMBRIC discovery pipelines.
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5. EMBRIC’s Scientific Output So Far
Experimental case studies have been an important activity since the very beginning of the EMBRIC
project. These studies are generally meant to (i) foster collaborations amongst participating Research
Infrastructures, (ii) explore how a user might utilize and combine individual components of the
EMBRIC cluster, and (iii) showcase the scientific potential of EMBRIC to marine stations and industrial
partners with the aim of getting them involved as collaborators at relevant stages of the respective
projects. Moreover, such case studies allow thorough testing of the proposed experimental workflows,
and EMBRIC case studies have thus been selected carefully to cover a broad range of the expertise
present within the EMBRIC network.
5.1. Marine Microalgal Pipeline: From Environment to Active Compounds
Marine microalgae comprise many types of organisms adapted to different environmental
conditions [1] and this translates into a great richness of potentially novel and unexplored metabolic
compounds [2]. To harness this potential, one EMBRIC case study aims to facilitate discovery of natural
products from unicellular algae that could be exploited for cosmetics, as well as for nutraceutical and
pharmaceutical applications. To achieve this ambitious goal, knowledge on microalgal biology; skills
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in identification, isolation, and cultivation of different species; a range of bioprofiling assays; and
expertise in compound isolation and characterization are needed. All these prerequisites exist within
the EMBRIC network, and one of the main efforts of this case study, led by the Stazione Zoologica
Anton Dohrn of Naples (SZN), is the set-up of a pipeline to connect laboratories across Europe, each
contributing their expertise and resources to provide individual workflows for compound isolation,
characterization, and production from microalgae (Figures 1 and 2). More specifically, this case study
is divided into two main parts: (i) the discovery of new natural products and (ii) the enhancement of
specific genetic traits for the efficient production of promising biomolecules by genetic engineering.
In the first part, eight partners with access to different marine ecosystems—by and large belonging
to the EMBRC and MIRRI Research infrastructures—are identifying, collecting, and growing microalgal
strains, thus providing the biological material for this case study. The range of laboratories involved
provides access to a broad variety of algae, from polar to warm-tempered species, with different sizes,
life strategies, and growth properties. Once sufficient material has been obtained, extracts are produced
from algal cell pellets at University of Nice Sophia Antipolis (UNS) and subsequently shipped to SZN in
duplicates for anti-proliferative and anti-oxidant assays [3]. Extracts generating hits in these bioprofiling
assays are further fractionated, and obtained fractions are re-tested to identify the biomolecule responsible
for the observed activity. In addition, the EU-OPENSCREEN partner HZI (Helmholtz Centre for Infection
Research) also receives copies of the extracts for screening in anti-bacterial assays, for pre-metabolomics
analyses that help identify the best conditions for algal cultivation, and for metabolomics profiling [4]).
Metabolomics data generated in this case study will all be made available through MetaboLights [5], a
publicly accessible database for metabolomics experiments and derived information. In the second part
of the case study, primary assay hits will get further optimized in order to enhance desired bioactivities
and maximize product yield in the respective algal strains or alternatively in heterologous expression
systems. To this end, genetic engineering is being exploited to produce microalgal strains overexpressing
genes linked to the production of interesting biomolecules in selected model species amenable to genetic
manipulation [6–8]. Moreover, with the aim to be able to better control genetics—in a similar way to
what is done for plants—experiments are conducted to induce sexual reproduction in the respective
model species. More information on the results obtained can be found on the project website, where all
EMBRIC deliverables are made publicly available (http://www.embric.eu/deliverables).
5.2. Marine Microbial Pipeline: From Environment to Active Compounds
A second case study—led by CAB International (CABI)—deals with releasing the potential of
recalcitrant marine bacteria (Figures 1 and 2). As marine bacteria are notoriously hard to isolate and
culture, the initial step of this project is to find appropriate culture conditions for those organisms in
order to obtain sufficient amounts of biomass for thorough characterization and downstream experiments.
To this end, substrate utilization profiles are produced at the Leibniz Institute DSMZ (German Collection of
Microorganisms and Cell Cultures) using fluorescent reporters and standard molecular biology techniques
to measure the response of individual bacteria to pulsed exposure to different substrates [9]. The obtained
profiles then allow the subsequent design of novel cultivation media for hitherto difficult to grow bacteria.
To establish and test the marine microbial pipeline five recalcitrant strains were selected and grown by the
DSMZ: Jejudonia soesokkakensis, Jannaschia donghaensis, Glaciihabitans tibetensis, Sphingopyxis contaminans, and
Marinifilum flexuosum. Many of these were originally isolated from biofilms in marine environments [10],
thus making them good candidates for the production of interesting new natural products.
Once enough biomass has been obtained, the metabolome of the respective bacterial strains will
be analysed and correlated with corresponding gene expression data generated by RNA-sequencing
(RNA-seq) to gain a better understanding of the gene clusters involved in the production of
the respective natural product. This information can then be used for heterologous expression
experiments—performed at University of St Andrews (USTAN)—which aim to identify, clone, and
express natural product gene synthesis clusters in standardized heterologous expression systems for
those bacterial strains for which no suitable culture conditions can be found.
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Moreover—analogous to the first case study—example natural products from these five recalcitrant
bacterial strains will be isolated and tested for interesting bioactivities by the EU-OPENSCREEN partner
HZI. This part of the project also involves mode-of-action analysis for isolated and structurally characterized
compounds; and interesting candidate molecules will be further optimized experimentally.
5.3. Aquaculture Genetics and Breeding Pipeline
More than half of all seafood consumption is now met from aquaculture following rising demand
from a growing and increasingly affluent world population and stagnation of traditional capture fisheries
due to over exploitation of stocks. It is estimated that by 2030, 93.6 million tons of seafood per year
will be produced from aquaculture, almost twice as much as in 2008 [11]. In contrast, aquaculture
production within the European Union has been static for more than a decade. Aquaculture is becoming
highly industrialized, requiring innovative technological solutions to solve production bottlenecks.
Major challenges include the provision of sustainably sourced feed supplies, the availability of suitable
production sites, and disease and welfare issues. Part of the answer to these global challenges lies in
increasing production efficiency, not least through the adoption of modern approaches to breeding
and broodstock genetics to improve growth feed conversion efficiency, disease resistance, and flesh
quality of farmed species [12]. EMBRIC is well placed to play an important role in supporting the
uptake of modern genetics in breeding programs because of the scale of its research capabilities in
‘omics’ techniques (EMBRC and MIRRI), bioinformatics (ELIXIR), and aquaculture (AQUAEXCEL2020).
This case study represents a pilot in the field of aquaculture genetics providing a common entry point to
all three Research Infrastructures involved through partners in the United Kingdom (USTAN, Marine
Science Scotland), France (French National Institute for Agricultural Research (INRA)), Greece (Hellenic
Centre for Marine Research), and Norway (University of Bergen). The development of sophisticated
genetic tools and the high-level skill sets in quantitative genetics and bioinformatics (Figure 1) needed to
implement genetic selection is beyond the capacity of most of the companies in a highly-fragmented
aquaculture sector, particularly small- and medium-sized enterprises. Innovation in aquaculture genetics
is dependent on the academic sector and a relatively restricted range of specialist genetic companies.
To ensure that the activities of this case study are relevant to the needs of industry, three SMEs have
been included as partners (Figure 2), Scalpro A/S (a Norwegian producer of scallop and oyster spat),
Tunatech GmbH (an innovative German aquaculture company), and Xelect Ltd. (a leading aquaculture
genetics service company based in Scotland).
The layout of this case study covers all the major aspects of breeding programs including (i) trait
measurements, (ii) the provision of genomic resources, and (iii) genetic marker discovery pipelines.
In the case of molluscs, established standards and ontologies for trait measurements were entirely
lacking. Without such standards, it is impossible to know whether different studies have measured
the same phenotypes, hampering comparative studies and precluding many types of meta-analyses
(Table 2). ELIXIR and USTAN have developed data standards and metadata requirements for shellfish
traits, including growth, meat yield, and toxin burden, enabling the integration of contextual information
with molecular data on the European Nucleotide Archive (https://www.ebi.ac.uk/ena). Feed represents
around 60% of production costs and is an important target trait for genetic selection [13]. Although Feed
Conversion Efficiency (FCE) shows moderate heritability, direct selection for this trait has not hitherto
been possible due to technical difficulties in measuring individual feed intake over the same timescale
that is required to estimate growth. The EMBRIC partner INRA from AQUAEXCEL2020 is currently
developing novel approaches to measure feed conversion efficiency and solve this bottleneck in European
sea bass (Dicentrarchus labrax). The feed efficiency project is in turn being used as a case study for the
EMBRIC Configurator service (www.embric.eu/node/1371) being developed by ELIXIR making use of
EMBRC partners as members of the expert panel to provide experimental advice. The aim is to produce
a description of all elements of infrastructure used in the study such as databases, standards, formats,
curation groups, analysis methods, and cloud computing capacity, and to provide advice on archiving
and accessibility of the data generated.
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Table 2. List of major bottlenecks identified in the EMBRIC discovery pipelines.
Current Bottlenecks (Aquaculture Pipeline: Finfish
and Shellfish; Breeding Pipeline) Suggested Solutions
The lack of genetic tools for many species The use of Next Generation Sequencing techniques to develop genomic resources including draft genomes,linkage maps, and marker panels
Poor control of inbreeding due to a lack of knowledge
about the pedigrees of broodstock in hatcheries Marker-based pedigrees and pipelines for SNP panel development
The need to identify the best broodstock The recording of precisely defined phenotypes involving common standards and ontologies. Methods for thecost-effective measurement of genetic variation at the genomic scale.
Current Bottlenecks (Microalgal and Microbial
Pipeline: Bacteria) Suggested Solutions
Cultivation of candidate organisms is often problematic,
with the yet uncultured and slow growing strains giving
low biomass production and high variability even within
the same species
Research Infrastructure partners follow harmonized best practices to minimize variation and engage
culturomics to design improved culture conditions and coordinate efforts [14–16].
Routes from crude extract assay hits to identifying and
purifying bioactive compounds are often problematic (for
example identifying the active component of extract and
its isolation)
It is possible to have coordinated access across and between RIs to utilise different technologies to identify
and design appropriate means to get from crude extracts to pure active compounds [17] utilizing
infrastructure best practice [18,19]; working towards the heterologous expression of the biosynthetic gene
cluster of interest and/or applying a genochemetic approach (undertaken in USTAN natural product
discovery pipeline).
Interoperability between data bases and data sets Research Infrastructures agree on common standards and ontologies.
Lack of information to find suitable candidate bacteria
with relevant activities for study and how to target them
in the environment
Contact MIRRI and EMBRC, who are making this knowledge available and have expertise in targeted
isolation [20]; keeping pace with new developments, e.g., symposia, which infrastructure partners follow
such as Natural Product Discovery and Development in the Genomic Era, organised by the Society for
Industrial Microbiology and Biotechnology: https://sim.confex.com/sim/np2018/meetingapp.cgi
Gaps in knowledge to be able to fully harness
metagenomics, proteomics, and metabolomics to identify
targets of interest with bioactive compounds or target
gene clusters in bacteria with the desired properties
Discovery can be enhanced by gene hunting and expression in host cells [19–21]; total DNA sequence data
from samples can be matched with known genes and specific genes can be targeted [19]; predicting potential
activities from the gene clusters is now possible [22]; reliable, verifiable, and efficient monitoring of
biodiversity can be achieved via metabarcoding [23]
J. Mar. Sci. Eng. 2018, 6, 81 9 of 12
A fundamental requirement of aquaculture breeding programs is the need to avoid inbreeding
depression, which reduces the fecundity growth and robustness of stocks. Inbreeding control requires
the development of genetic marker panels and software for pedigree reconstruction and parentage
assignment (Table 2). The genomic resources available for molluscs are sparse relative to finfish,
which, coupled with much higher levels of nucleotide diversity and life history characteristics such as
high fecundity and the incidence of hermaphroditism with potential for self-fertilization, provides
particular challenges for inbreeding control [24]. USTAN and Xelect have generated genomic data
sets for several cultured molluscs and are exploring the use of information-rich haplotype markers
as a novel approach to parentage assignment using high throughput genotyping using sequencing
methods with the aim of providing a more efficient means of inbreeding control in these species.
EMBRIC partners have also used a sequence data set from the complex duplicated Atlantic salmon
genome to design an efficient bioinformatics pipeline for the development and validation of parentage
assignment panels, which is applicable to any aquaculture species [25]. HCMR, a partner in EMBRC,
ELIXIR, and AQUAEXCEL2020, and Xelect Ltd., have been developing bioinformatics pipelines for
resequencing bluefin tuna and Atlantic salmon genomes respectively. Together with collaborators at
the University of Aberdeen, Xelect has mapped population variation in local genome duplications and
insertions, so-called Copy Number Variation (CNVs). CNVs have the potential to become an entirely
new class of selection markers in animal breeding.
5.4. The EMBRIC Company Forums
To further facilitate knowledge exchange between EMBRIC and the industrial sector, a first
“Company Forum” was established with the aim of focusing effort on shared research priorities and
disseminating the outputs of the pilot studies. EMBRIC supports open data policies and aims to
encourage greater levels of business to business collaboration at precompetitive stages to the benefit of
all players in the European aquaculture sector. The aquaculture Company Forum is led by TunaTech
GmbH and supported by an advisory board drawn from academia and industry (http://www.embric.
eu/companyfora/aquaculture). The Company Forum held a well-attended and successful workshop
at the European Aquaculture Society (EAS) Meeting in Edinburgh in September 2016 with a key note
speaker from the Scottish Shellfish industry A meeting in Bergen in May 2018 discussed Advances
in Industrial Aquaculture Genetics—North meets South. Further meetings of the Company Forum to
disseminate the outputs of EMBRIC and encourage use of the involved Research Infrastructures by
academic groups and industry are planned, for example the EAS Meeting in Montpellier in August 2018
(see http://www.embric.eu/node/1191). In order to establish a similar format for the EMBRIC natural
product discovery projects, a Microalgae Company Forum has been launched at the AlgaEurope
conference in December 2017 in Berlin: this Forum will help academic and industrial partners with
the set-up of bio-assays to identify novel bioactive compounds, and will allow access to microalgal
collections and to compound libraries (http://www.embric.eu/companyfora/microalgae).
5.5. Identified Bottlenecks and Suggested Solutions
The work conducted in the natural product discovery case studies has highlighted a number
of bottlenecks to progress (see Table 2). Among the most common issues is that partners have
reported inconsistency in growth when scaling up culture volumes; difficulty in obtaining sufficient
biomass from some species or growth conditions; and high variability in the metabolism of different
strains from the same species, which can lead to low reproducibility. Maintaining detailed records of
sample growth conditions with appropriate software and databases is certainly required to minimize
variation. Furthermore, while important preliminary data on bio-activities and metabolic profiles can
be easily obtained for hundreds of samples, the isolation of pure compounds is currently a limiting
step that cannot be easily automated; rather, it requires dedicated personnel, time, and resources.
Pure compounds will certainly attract more industrial partners because of the opportunity to readily
test them for different applications.
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Bottlenecks that are being addressed in the selective breeding case study include the lack trait
measurement standards and availability of genomic resources for certain species, as well as the need
to reduce genotyping costs in order to implement cost effective genomic selection in species with a
low individual value (Table 2). Genomic selection involves genotyping and phenotyping a reference
population to develop a genomic prediction algorithm to estimate breeding values that are more
accurate than those derived from pedigree information alone [26]. Selection candidates are only
genotyped, making the method particularly suitable for destructive traits such as disease resistance
and meat yield. Genomic selection requires no knowledge of the underlying mechanism linking
phenotype to genotype, and it is suitable for traits controlled by hundreds or even thousands of genes
of small individual effect. In other livestock species such as dairy cattle, it relies on the use of high
density SNP panels to enable brood stock to be genotyped at many tens or hundreds of thousands of
loci across the genome, such that SNPs responsible for the trait variation are in linkage disequilibrium
with one or more SNPs on the marker panel. A bottleneck for implementing genomic selection in
aquaculture, particularly for medium sized companies, is the high cost of genotyping. Solutions to this
bottleneck, in cases in which a genome is available, include genotyping the parents with a medium
density SNP chip and using imputation techniques to genotype the more numerous offspring with a
much lower density, allowing the use of a cheaper marker panel (Table 2).
6. Outlook
The examples provided above are the mere tip of the iceberg of what will be possible in the
future. With the network established and the discovery pipelines proven functional, EMBRIC has now
reached the point where it can start to make its resources and expertise accessible to external users from
academia and industry. The EMBRIC Consortium has set aside a dedicated budget for transnational
access to EMBRIC partners; the first round of external research projects is ongoing. The aim of this
funding call is to start addressing major bottlenecks that have been identified so far during the setup of
the discovery pipelines and that currently prevent full exploitation of the marine innovation potential.
A second transnational funding call has opened in February 2018 building on the users’ needs and the
lessons learned from the first round of funding.
Generally, transnational access is offered by 15 access providers belonging to four different
Research Infrastructures (AQUAEXCEL2020, EMBRC, EU-OPENSCREEN, and MIRRI) in seven
European countries. Users of the transnational access program can be scientists from academia or
industry, with their home institutions based in EU member states or associated countries (as defined
by the Horizon 2020 programme). Access for user groups with a majority of users not working in EU
Member States or Associated Countries is limited to 20% of the total amount of units of access provided.
Because of its multidisciplinary nature, the second round of transnational access funding will
continue to raise awareness of marine translational science across many different research areas and
will thus help to accelerate blue innovation through cross-disciplinary collaboration—as the Japanese
poet Ryunosuke Satoro once put it: “Individually, we are one drop. Together, we are an ocean”.
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